Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome — Stella

Home/Short Bowel Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Short Bowel Syndrome trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Cleveland Clinic Main Campus, Cleveland, Ohio

Key details

Phase

Very early testing

Sponsor

Lindsey Russell, MD

Collaborators

Napo Pharmaceuticals, Inc.

Enrollment target

~6 participants

Started

March 2025

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.